All In MedTech

Device Trial Radar · NCT04040387

NightWare Randomized Trial 02

TNT/NW: Traumatic Nightmares Treated by NightWare (To Arouse Not Awaken)

Last checked: Nov 19, 2026Latest source record: Apr 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 270 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

270

Actual

Start

Jul 24, 2019

Primary completion

May 31, 2025

Study completion Aug 2, 2025

Sponsor

Lead sponsor
NightWareNot on our public-company list
Sponsor type
Industry
Collaborators
Minneapolis Veterans Affairs Medical Center; Louis Stokes VA Medical Center; Walter Reed National Military Medical Center; Ralph H. Johnson VA Medical Center
First posted
Jul 31, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will provide preliminary estimates of safety and efficacy of the NightWare digital therapeutic system (iPhone + Apple watch + proprietary application) for the treatment of nightmare disorder associated with post-traumatic stress disorder (PTSD)-related sleep disturbance and the impact of improved sleep with the NightWare digital therapeutic system. The investigators hypothesize that the NightWare digital therapeutic system will significantly improve sleep quality in participants with PTSD-Related nightmares and poor sleep quality.

Conditions

  • Stress Disorders, Post-Traumatic
  • Combat Disorders
  • Ptsd
  • Nightmare
  • Nightmares, REM-Sleep Type
  • Nightmare Disorder With Associated Non-Sleep Disorder

Interventions

  • NightWare Therapeutic SystemDevice

    A wearable digital therapeutic system that will measure physiologic data when worn during sleep to deliver a mild vibration via the watch to elicit arousal thereby disrupting nightmares. This detection and stimulation sequence will be performed according to NightWare's proprietary algorithm.

  • Sham NightWareDevice

    NightWare device not providing interventions

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in global score on the Pittsburgh Sleep Quality Index (PSQI) from Day 0 to Day 30Time frame: 0-90 days

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Walter Reed National Military Medical Center

    Bethesda, Maryland

  • Minneapolis VA Healthcare System

    Minneapolis, Minnesota

  • Louis Stokes Cleveland VA Medical Center

    Cleveland, Ohio

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.